ArticleBlood advances2025

Genome-wide CRISPR/Cas9 screen identifies AraC-daunorubicin-etoposide response modulators associated with outcomes in pediatric AML.

Nam H K Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.